Chemoinformaics analysis of (E,Z)-1,3,5-Tridecatriene-7,9,11-triyne
| Molecular Weight | 166.223 | nRot | 2 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 6 |
| Exact Molecular Weight | 166.078 | nRing | 0 |
| Solubility: LogS | -4.593 | nHRing | 0 |
| Solubility: LogP | 4.175 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 28.3779 |
| nHD | 0 | BPOL | 10.0321 |
| QED | 0.436 |
| Synth | 4.19 |
| Natural Product Likeliness | 3.343 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.05 |
| CACO-2 | -3.745 |
| MDCK | 0.0000981 |
| BBB | 0.001 |
| PPB | 1.01798 |
| VDSS | 0.874 |
| FU | 0.0320438 |
| CYP1A2-inh | 0.981 |
| CYP1A2-sub | 0.124 |
| CYP2c19-inh | 0.936 |
| CYP2c19-sub | 0.699 |
| CYP2c9-inh | 0.898 |
| CYP2c9-sub | 0.642 |
| CYP2d6-inh | 0.922 |
| CYP2d6-sub | 0.707 |
| CYP3a4-inh | 0.91 |
| CYP3a4-sub | 0.308 |
| CL | 6.817 |
| T12 | 0.101 |
| hERG | 0 |
| Ames | 0.481 |
| ROA | 0.923 |
| SkinSen | 0.97 |
| Carcinogencity | 0.271 |
| EI | 0.992 |
| Respiratory | 0.849 |
| NR-Aromatase | 0.231 |
| Antiviral | No |
| Prediction | 0.701867 |